Low-grade inflammation in individuals with the hypertriglyceridemic waist phenotype: Another feature of the atherogenic dysmetabolism

被引:19
作者
Rogowski, Ori [1 ,2 ,3 ,4 ]
Shapira, Itzhak [1 ,2 ,3 ,4 ]
Steinvil, Arle [1 ,2 ,3 ,4 ]
Berliner, Shlomo [1 ,2 ,3 ,4 ]
机构
[1] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Med D, IL-64239 Tel Aviv, Israel
[2] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Med E, IL-64239 Tel Aviv, Israel
[3] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Inst Special Med Examinat MALRAM, IL-64239 Tel Aviv, Israel
[4] Tel Aviv Univ, Sackler Fac Med, IL-64239 Tel Aviv, Israel
来源
METABOLISM-CLINICAL AND EXPERIMENTAL | 2009年 / 58卷 / 05期
关键词
C-REACTIVE PROTEIN; ATHEROTHROMBOTIC RISK-FACTORS; CORONARY-ARTERY-DISEASE; METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE; ABDOMINAL OBESITY; SEX-DIFFERENCES; DENSE LDL; PREDICTION; PREVALENCE;
D O I
10.1016/j.metabol.2009.01.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The purpose of this study was to explore the possibility that the recently described "hypertriglyceridemic waist" (HTGW) phenotype, a risk for future coronary artery disease, is associated with the presence of low-grade inflammation. This is a cross-sectional study in a cohort of apparently healthy nondiabetic employed individuals in whom the presence of low-grade inflammation was determined by using the Dade Behring high-sensitivity C-reactive protein (hs-CRP) assay. We have presently analyzed the results obtained in 9842 apparently healthy individuals, at a mean (SD) age of 44 (11) years. We identified 1249 individuals (70.0% men) with HTGW phenotype according to the cutoff points of waist girth of at least 90 cm for men and at least 85 cm for women and triglycerides levels of at least 177 mg/dL for men and at least 133 mg/dL for women. In addition, we identified 1164 individuals (69.3% men) with the metabolic syndrome (MetS) according to the updated Adult Treatment Panel III criteria. The mean (SD) of hs-CRP was 1.3 (2.9) mg/L for the 8055 individuals who had neither the HTGW phenotype nor the MetS, 2.1 (2.7) mg/L for those who had the HTGW phenotype and no MetS, and 2.5 (2.7) for 539 individuals with the MetS and no HTGW phenotype, whereas those who had both atherogenic disorders presented an hs-CRP concentration of 2.9 (2.3) mg/L. In this cohort of apparently healthy nondiabetic employed individuals, the HTGW phenotype had a similar prevalence as the MetS and was associated with the presence of low-grade inflammation. This inflammation could be a pathophysiologic link between this dysmetabolism and atherothrombosis. In addition, the HTGW phenotype is relatively prevalent and could be a simple and inexpensive way to sing,le out individuals at risk for future coronary artery disease. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:661 / 667
页数:7
相关论文
共 33 条
[1]   Erythrocyte adhesiveness/aggregation; A novel biomarker for the detection of low-grade internal inflammation in individuals with atherothrombotic risk factors and proven vascular disease [J].
Berliner, S ;
Rogowski, O ;
Aharonov, S ;
Mardi, T ;
Tolshinsky, T ;
Rozenblat, M ;
Justo, D ;
Deutsch, V ;
Serov, J ;
Shapira, I ;
Zeltzer, D .
AMERICAN HEART JOURNAL, 2005, 149 (02) :260-267
[2]   Type 2 diabetes without the atherogenic metabolic triad does not predict angiographically assessed coronary artery disease in women [J].
Blackburn, Patricia ;
Lemieux, Isabelle ;
Lamarche, Benoit ;
Bergeron, Jean ;
Perron, Patrice ;
Tremblay, Gerald ;
Gaudet, Daniel ;
Despres, Jean-Pierre .
DIABETES CARE, 2008, 31 (01) :170-172
[3]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[4]   Metabolic syndrome - A comprehensive perspective based on interactions between obesity, diabetes, and inflammation [J].
Dandona, P ;
Aljada, A ;
Chaudhuri, A ;
Mohanty, P ;
Garg, R .
CIRCULATION, 2005, 111 (11) :1448-1454
[5]   Increased thrombosis after arterial injury in human C-reactive protein - Transgenic mice [J].
Danenberg, HD ;
Szalai, AJ ;
Swaminathan, RV ;
Peng, L ;
Chen, ZP ;
Seifert, P ;
Fay, WP ;
Simon, DI ;
Edelman, ER .
CIRCULATION, 2003, 108 (05) :512-515
[6]   Abdominal obesity and the metabolic syndrome:: Contribution to global cardiometabolic risk [J].
Despres, Jean-Pierre ;
Lemieux, Isabelle ;
Bergeron, Jean ;
Pibarot, Philippe ;
Mathieu, Patrick ;
Larose, Eric ;
Rodes-Cabau, Josep ;
Bertrand, Olivier F. ;
Poirier, Paul .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (06) :1039-1049
[7]   Abdominal obesity and metabolic syndrome [J].
Despres, Jean-Pierre ;
Lemieux, Isabelle .
NATURE, 2006, 444 (7121) :881-887
[8]   Prevalence of the hypertriglyceridemic waist phenotype in Iranian adolescents [J].
Esmaillzadeh, A ;
Mirmiran, P ;
Azadbakht, L ;
Azizi, F .
AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2006, 30 (01) :52-58
[9]  
Esmaillzadeh A, 2005, AM J CLIN NUTR, V81, P55
[10]   The hypertriglyceridemic waist phenotype is a predictor of elevated levels of small, dense LDL cholesterol [J].
Gazi, Irene F. ;
Filippatos, Theodosios D. ;
Tsimihodimos, Vasilis ;
Saougos, Vasilios G. ;
Liberopoulos, Evangelos N. ;
Mikhailidis, Dimitri P. ;
Tselepis, Alexandros D. ;
Elisaf, Moses .
LIPIDS, 2006, 41 (07) :647-654